Arbutus Biopharma Corp
Recent Filings
All 1,000 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Naftzger J. Christopher | General Counsel and CCO | Award / Grant | 54,300 | 140,544 | Feb 14, 2025 |
| McElhaugh Michael J. | Interim President & CEO | Award / Grant | 177,000 | 1,658,003 | Feb 14, 2025 |
| HASTINGS DAVID C | Chief Financial Officer | Award / Grant | 90,100 | 249,824 | Feb 14, 2025 |
| Sims Karen | Chief Medical Officer | Award / Grant | 49,300 | 155,494 | Feb 14, 2025 |
| HASTINGS DAVID C | Chief Financial Officer | Sale | 22,183 @ $3.28 | 159,724 | Feb 4, 2025 |
| Sims Karen | Chief Medical Officer | Sale | 19,348 @ $3.28 | 106,194 | Feb 4, 2025 |
| McElhaugh Michael J. | Interim President & CEO | Sale | 23,790 @ $3.28 | 1,481,003 | Feb 4, 2025 |
| Naftzger J. Christopher | General Counsel and CCO | Sale | 11,333 @ $3.28 | 86,244 | Feb 4, 2025 |
| Naftzger J. Christopher | General Counsel and CCO | Award / Grant | 95,100 | 95,100 | Feb 1, 2024 |
| Sims Karen | Chief Medical Officer | Sale | 4,358 @ $2.31 | 125,542 | Feb 1, 2024 |